{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3492, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a Venn diagram to illustrate target overlap and a tree diagram to show potential combination therapy paths.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/44", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a comparative framework to validate the efficacy of CDx-guided patient selection.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/45", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-45", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/46", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout for headshots and a logo cloud at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/47", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/48", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart uses a custom range bar (min/max) with markers for IPO and Today's market cap.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/49", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-49", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "peer_benchmark", "function": "cite_precedent", "notes": "The slide uses a timeline-based comparison to suggest that Spyre's assets are on a similar trajectory to high-value acquired assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/50", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-50", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/51", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-51", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "team_bio", "function": "cite_precedent", "notes": "The slide serves as a credibility transfer by showcasing the partner's team and achievements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/52", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-52", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/53", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a pentagon diagram to represent the five pillars of their antibody engineering platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/54", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-54", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "solution", "function": "present_solution", "notes": "The diagram illustrates the mechanism of FcRn-mediated antibody recycling, contrasting physiological affinity with high affinity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/55", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-55", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "solution", "function": "present_solution", "notes": "Includes two distinct chart types: a scatter plot for half-life correlation and bar charts for ADA rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/56", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-56", "loopMatches": [], "arcBeatMatches": [ { "to": 56, "from": 45, "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document calls for action, outlining the company's plans and milestones", "position": 5, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/Om7uiShJX08bEHNwYotA6kCAXE3VnjhDSKsoa2u2x3k/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YTVhMWNiMmQyMzQzOWExZjNmZGEyZDUxNzViMTBiNS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/1", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "8eb4d034-ff60-4d47-90ea-4884540a4ecb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "The presentation begins with a cover slide, disclaimer, and section divider, setting the stage for the Q2 2023 financial performance review.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": "https://imgproxy.kitesheet.com/ESC-87j6aHx_t7RlO-IBNMFf3MA1E_cuPWkqMZYa5vo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YTVhMWNiMmQyMzQzOWExZjNmZGEyZDUxNzViMTBiNS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/5wgetDpAP-s_KN3deA9qlp06mSVtBhORIlCQzzVjUcM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YTVhMWNiMmQyMzQzOWExZjNmZGEyZDUxNzViMTBiNS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/NvN7ftYqZdDoLylFuQKwDifVQYUf_jM6sNPB1F2fxPU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YTVhMWNiMmQyMzQzOWExZjNmZGEyZDUxNzViMTBiNS9wMDAxLnBuZw" }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/2", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "8eb4d034-ff60-4d47-90ea-4884540a4ecb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "The presentation begins with a cover slide, disclaimer, and section divider, setting the stage for the Q2 2023 financial performance review.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/3", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "8eb4d034-ff60-4d47-90ea-4884540a4ecb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "The presentation begins with a cover slide, disclaimer, and section divider, setting the stage for the Q2 2023 financial performance review.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes explaining the impact of Janssen arbitration on financial results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/4", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "8eb4d034-ff60-4d47-90ea-4884540a4ecb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "The presentation begins with a cover slide, disclaimer, and section divider, setting the stage for the Q2 2023 financial performance review.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes regarding arbitration and product definitions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/5", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table includes a blue box highlighting the Q2 2023 column. Footnotes explain the impact of an arbitration settlement on Manufacturing & Royalty Revenue.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/6", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a disclaimer regarding the separation of the oncology business and a footnote about non-GAAP reconciliation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/7", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-7", "loopMatches": [ { "to": 11, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9", "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.", "position": 0, "objective": "What are the implications of not achieving topline growth and diversification?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/8", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-8", "loopMatches": [ { "to": 11, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9", "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.", "position": 0, "objective": "What are the implications of not achieving topline growth and diversification?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart illustrates revenue diversification across four products: VIVITROL, ARISTADA, VUMERITY, and LYBALVI.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/9", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-9", "loopMatches": [ { "to": 11, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9", "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.", "position": 0, "objective": "What are the implications of not achieving topline growth and diversification?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 11, "from": 9, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "d07d2911-1274-4deb-8262-177be0bf2ba5", "evidence": "Slides 9-11 provide an overview of LYBALVI prescription growth trends, implying that customer feedback and market data are driving the company's commercial strategies.", "position": 1, "objective": "What do customers think about LYBALVI prescription growth trends?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart displays both weekly data and a 4-week rolling average.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/10", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-10", "loopMatches": [ { "to": 11, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9", "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.", "position": 0, "objective": "What are the implications of not achieving topline growth and diversification?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 11, "from": 9, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "d07d2911-1274-4deb-8262-177be0bf2ba5", "evidence": "Slides 9-11 provide an overview of LYBALVI prescription growth trends, implying that customer feedback and market data are driving the company's commercial strategies.", "position": 1, "objective": "What do customers think about LYBALVI prescription growth trends?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/11", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-11", "loopMatches": [ { "to": 11, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9", "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.", "position": 0, "objective": "What are the implications of not achieving topline growth and diversification?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 11, "from": 9, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "d07d2911-1274-4deb-8262-177be0bf2ba5", "evidence": "Slides 9-11 provide an overview of LYBALVI prescription growth trends, implying that customer feedback and market data are driving the company's commercial strategies.", "position": 1, "objective": "What do customers think about LYBALVI prescription growth trends?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart includes a vertical dashed line separating historical data from the most recent quarter.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/12", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/13", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Performance Indicator Overview", "beatSlug": null, "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/14", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 14, "beatId": "5d9219ab-1e3b-42c3-8cfa-e46da901ca72", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Appendix", "beatSlug": null, "evidence": "Slides 14-16 provide additional data and information, including financial results and GAAP to Non-GAAP adjustments.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/15", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 14, "beatId": "5d9219ab-1e3b-42c3-8cfa-e46da901ca72", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Appendix", "beatSlug": null, "evidence": "Slides 14-16 provide additional data and information, including financial results and GAAP to Non-GAAP adjustments.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes specific line items for share-based compensation, depreciation, amortization, separation expenses, tax effects, non-cash interest, and a significant Janssen arbitration award.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/16", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 14, "beatId": "5d9219ab-1e3b-42c3-8cfa-e46da901ca72", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Appendix", "beatSlug": null, "evidence": "Slides 14-16 provide additional data and information, including financial results and GAAP to Non-GAAP adjustments.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3db6-70cc-be39-8d329d3330a5", "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5", "documentTitle": "Alkermes | Results Presentation Deck | 17 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "closing_ask", "function": "closing_ask", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/17", "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5", "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 17, "beatId": "652a6c4b-007b-4c22-808e-ce0957e1fbdc", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Closing Ask", "beatSlug": null, "evidence": "The final slide serves as a closing ask, summarizing the presentation's key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/zhrApyfn9pZpJREgu9tGg4gph1vPfP9KXxEB7uTFv-4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/1", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/D4l7CX9HKvmqCj_AtmW5c1PGBL62skop44QAt-vXRHI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/l6uYpY6Sr5CpacBlKPag7U5Bh07Z2gw8XDkBuqEV5WE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/lSoJdRK7gJc7FdEt1EIMpEqzP_cHglwU9Ok2dPYOu10/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLnBuZw" }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/2", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "thesis_headline", "function": "establish_context", "notes": "The slide uses a corporate branding background with a network/molecular overlay.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/3", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-3", "loopMatches": [ { "to": 3, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "627b70f9-6545-44ba-bd44-65abf965472d", "evidence": "The presentation starts with the company's mission", "position": 0, "objective": "Understand the company's mission and purpose", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 3, "from": 3, "beatId": "74736298-c289-40a8-aa54-f67833c03a44", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Why", "beatSlug": "golden-circle-why", "evidence": "Our mission is to transform severe autoimmunity", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a circular, iterative process diagram to represent the growth strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/4", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "4042a4ac-577c-44e4-b46e-0e8cd8bee312", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Key Messages", "beatSlug": null, "evidence": "Driving Sustained Growth Across the Business", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "before_after", "function": "analyze_data", "notes": "Kaplan-Meier survival curve showing probability of no relapse over 48 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/5", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-5", "loopMatches": [ { "to": 5, "from": 5, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "54f76381-9824-4185-9ad1-e421511382fa", "evidence": "The before-after comparison shows the opportunity to transform CIDP patient experience", "position": 1, "objective": "Highlight the benefits of ADHERE", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "05492dc3-bfd3-470d-936c-bceffef47c97", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "ADHERE: Opportunity to Transform CIDP Patient Experience", "position": 2, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/6", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-6", "loopMatches": [ { "to": 6, "from": 6, "name": "Maturity Curve", "slug": "36-maturity-curve", "bestFor": "Digital transformation, capability building, benchmarking", "matchId": "230fe403-8201-4db8-b7ec-38b6ac18620a", "evidence": "The roadmap shows the potential for empasiprubart across diseases", "position": 2, "objective": "Show the opportunity across multiple autoimmune diseases", "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap", "confidence": 0.6, "description": "Show where you are on a progression and what it takes to reach the next level" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "e5d868bb-c506-47e5-9a5e-b29673084011", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Roadmap", "beatSlug": null, "evidence": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "other", "function": "establish_context", "notes": "The slide uses a bubble-based layout to display various brand and study logos centered around the main argenx corporate logo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/7", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a callout for cash position at end of Q2 2023.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/8", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-8", "loopMatches": [ { "to": 8, "from": 8, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "200eef78-7315-464a-8d05-b0328f02313f", "evidence": "The second quarter 2023 finance summary provides key financial data", "position": 3, "objective": "Highlight key financial metrics", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 8, "from": 8, "beatId": "2f734848-fe4a-4326-85c7-7c02941ec394", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "KPIs", "beatSlug": null, "evidence": "Second Quarter 2023 Finance Summary", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a 3D-like coordinate system to represent growth vectors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/9", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "b54d724a-8f41-4c49-9bc3-48af2bd5d477", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Roadmap", "beatSlug": null, "evidence": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a central circular image overlaying key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/10", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_messages", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/11", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 11, "beatId": "74fbf466-b91f-4652-ac49-e35b08e26f8a", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Key Messages", "beatSlug": null, "evidence": "VYVGART Simplifies Treatment for Autoimmune Diseases", "position": 6, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "geographic_map", "function": "establish_context", "notes": "The slide uses a map to visualize geographic reach, paired with two tables detailing approval timelines for two different products.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/12", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide uses a patient story to humanize the clinical goals of minimizing burden and achieving sustained responses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/13", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a process-oriented layout to show how strategic pillars are supported by specific operational achievements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/14", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-14", "loopMatches": [ { "to": 14, "from": 14, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "99e2a2b7-1876-4e0a-8bbd-5a411ee2a163", "evidence": "The key takeaways section highlights the company's commitment to delivering value", "position": 4, "objective": "Emphasize continuous value creation", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.7, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 14, "beatId": "089a9db0-b394-4447-ad13-a45a78b7e68a", "arcName": "The Golden Circle", "arcSlug": "golden-circle", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Delivering on the Promise of Continuous Value Creation", "position": 7, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "docSlug": "085543019d5934281487d90fc26e88a2", "documentTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_messages", "function": "present_framework", "notes": "The diagram is a hub-and-spoke model representing corporate values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/15", "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/UzYW-2JBL4cYvjJgenvhSGR_zOB1IUEsVywVhfzn79g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hYzU3NzNlNTNjNWIyYTAxNjI3NTcxNGRlYjcxMDMzZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/1", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/vlymHZNEzDPXP7UdRMDVKLWCjhxszi79N-Nr9gaUF8w/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hYzU3NzNlNTNjNWIyYTAxNjI3NTcxNGRlYjcxMDMzZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/nD-2g7PJVNpOyK_xZNiIssebFQx5lyobojlZuYMh4uI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hYzU3NzNlNTNjNWIyYTAxNjI3NTcxNGRlYjcxMDMzZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/s_KsYh1Yzi8EGOJN323JXeiuX3WrfAh-KmkG4Vb7tLc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hYzU3NzNlNTNjNWIyYTAxNjI3NTcxNGRlYjcxMDMzZS9wMDAxLnBuZw" }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/2", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a list-based layout to present three key clinical findings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/3", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "thesis_headline", "function": "establish_context", "notes": "The slide uses a high-level mission statement as the primary anchor for the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/4", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide uses a central portrait of a patient (Crystal) to humanize the clinical data points surrounding her.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/5", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "pain_points", "function": "diagnose_problem", "notes": "The slide uses a spiral/funnel-like diagram to illustrate the compounding nature of patient challenges.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/6", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-6", "loopMatches": [ { "to": 6, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "c5a3e47b-5d9a-49ff-b1d2-accf74764270", "evidence": "The presentation highlights the need for new options, implying a cost of inaction", "position": 0, "objective": "What is the cost of not adopting argenx SE's solution?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "cfd729c6-c2ab-4566-b149-bb5b2f1d075c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slide 6 highlights CIDP patients' desperate need for new options", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 6, "from": 6, "beatId": "fc775f0f-4fd5-4e1f-8689-b4d489acbbb0", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The same slide agitates the situation by emphasizing the desperation", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the patient journey through the trial, including specific durations and transition criteria.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/7", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays mean (SD) or n (%) for various clinical metrics including age, gender, diagnosis duration, and disease activity scores.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/8", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights efficacy across different patient subsets and mentions specific clinical metrics (INCAT, I-RODS, grip strength).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/9", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a Kaplan-Meier plot to demonstrate clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/10", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes hazard ratios, p-values, and mean changes from baseline for CIDP disease progression and functional scores.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/11", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide presents clinical trial safety data for VYVGART Hytrulo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/12", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "before_after", "function": "frame_situation", "notes": "Uses a 'before-after' framing to contrast legacy treatments (IVIg, Steroids, PLEX) with the new product's benefits.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/13", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-13", "loopMatches": [ { "to": 13, "from": 13, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "7c8c3e73-d3a1-4f4d-9710-fafacf3a1ea9", "evidence": "The presentation shows how argenx SE can revolutionize the patient experience", "position": 1, "objective": "How can argenx SE improve the CIDP patient experience?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_messages", "function": "establish_context", "notes": "The slide uses a bubble-based layout to showcase brand logos and study names centered around the corporate brand.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/14", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3ef2-720b-a168-5d01d166fded", "docSlug": "ac5773e53c5b2a016275714deb71033e", "documentTitle": "argenx SE | Results Presentation Deck | 16 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-column layout to categorize progress into Clinical, Regulatory, and Revenue pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/15", "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded", "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 3, "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 3 to 15 present the solution and positive results", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 16, "from": 15, "beatId": "9779ee11-b9ba-4fff-9eae-b1ea3e55513b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The final slides encourage action and next steps", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }